A detailed history of Frazier Financial Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Frazier Financial Advisors, LLC holds 28,368 shares of ABT stock, worth $3.3 Million. This represents 2.51% of its overall portfolio holdings.

Number of Shares
28,368
Previous 28,729 1.26%
Holding current value
$3.3 Million
Previous $2.99 Billion 8.34%
% of portfolio
2.51%
Previous 2.37%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$100.07 - $118.13 $36,125 - $42,644
-361 Reduced 1.26%
28,368 $3.23 Billion
Q2 2024

Aug 12, 2024

BUY
$100.73 - $112.44 $101,435 - $113,227
1,007 Added 3.63%
28,729 $2.99 Billion
Q1 2024

May 13, 2024

SELL
$109.52 - $120.96 $623,387 - $688,504
-5,692 Reduced 17.03%
27,722 $3.15 Billion
Q4 2023

Feb 09, 2024

BUY
$90.19 - $110.4 $3.01 Million - $3.69 Million
33,414 New
33,414 $3.68 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $204B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Frazier Financial Advisors, LLC Portfolio

Follow Frazier Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frazier Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frazier Financial Advisors, LLC with notifications on news.